Talat Nasim

2.0k total citations
26 papers, 902 citations indexed

About

Talat Nasim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Talat Nasim has authored 26 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Talat Nasim's work include Pulmonary Hypertension Research and Treatments (7 papers), RNA Research and Splicing (7 papers) and Bone health and treatments (4 papers). Talat Nasim is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), RNA Research and Splicing (7 papers) and Bone health and treatments (4 papers). Talat Nasim collaborates with scholars based in United Kingdom, Türkiye and United States. Talat Nasim's co-authors include Jamie J.L. Williams, Timothy M. Palmer, Ian C. Eperon, Richard C. Trembath, Rajendran C. Gopalan, Geoffrey W. Birrell, Rick Woods, Martin F. Lavin, Olivier J. Bécherel and Yi Chieh Lim and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Talat Nasim

26 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Talat Nasim United Kingdom 17 471 177 135 82 73 26 902
Thomas A. Rado United States 17 423 0.9× 276 1.6× 149 1.1× 77 0.9× 32 0.4× 34 942
Chia‐Hui Lin Taiwan 18 453 1.0× 87 0.5× 74 0.5× 113 1.4× 38 0.5× 71 1.0k
Patricia M. Scott United States 16 628 1.3× 217 1.2× 166 1.2× 113 1.4× 25 0.3× 24 1.3k
Ewa D. Micewicz United States 15 304 0.6× 102 0.6× 118 0.9× 168 2.0× 14 0.2× 31 797
Yang Wu China 20 513 1.1× 175 1.0× 301 2.2× 189 2.3× 98 1.3× 73 1.2k
Ximeng Han China 14 340 0.7× 88 0.5× 70 0.5× 77 0.9× 44 0.6× 24 909
Yuriy O. Alekseyev United States 21 781 1.7× 333 1.9× 207 1.5× 112 1.4× 37 0.5× 48 1.3k
Tobias N. Cassel Sweden 17 639 1.4× 297 1.7× 269 2.0× 61 0.7× 49 0.7× 22 1.1k
Martina Klünemann Germany 5 446 0.9× 91 0.5× 126 0.9× 108 1.3× 10 0.1× 9 687

Countries citing papers authored by Talat Nasim

Since Specialization
Citations

This map shows the geographic impact of Talat Nasim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Talat Nasim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Talat Nasim more than expected).

Fields of papers citing papers by Talat Nasim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Talat Nasim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Talat Nasim. The network helps show where Talat Nasim may publish in the future.

Co-authorship network of co-authors of Talat Nasim

This figure shows the co-authorship network connecting the top 25 collaborators of Talat Nasim. A scholar is included among the top collaborators of Talat Nasim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Talat Nasim. Talat Nasim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasim, Talat, et al.. (2025). The Effects of Antipsychotic Drugs and Non-Pharmacological Therapies on Schizophrenia. Kent Academic Repository (University of Kent). 3(1). 10–10. 2 indexed citations
2.
Haddad, Fatma, Anant Paradkar, Mojgan Najafzadeh, et al.. (2024). Development and evaluation of liquid formulations of chrysin and budesonide for asthma and COPD; evaluation of the formulations’ genotoxicity and anti-inflammatory activity. Journal of Drug Delivery Science and Technology. 105. 106567–106567. 1 indexed citations
3.
Makanjuola, David, Khaled Habas, K.H. Assi, et al.. (2024). Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products. Kent Academic Repository (University of Kent). 2(4). 428–445. 1 indexed citations
4.
Nasim, Talat, et al.. (2024). The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension. SHILAP Revista de lepidopterología. 4(3). 236–251. 1 indexed citations
5.
6.
Nasim, Talat, et al.. (2021). Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension. Trends in Pharmacological Sciences. 42(7). 510–513. 18 indexed citations
7.
Williams, Jamie J.L., et al.. (2019). Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease. Trends in Pharmacological Sciences. 40(5). 298–308. 137 indexed citations
8.
Hu, Jing, Alireza Khodadadi‐Jamayran, Miaowei Mao, et al.. (2016). AKAP95 regulates splicing through scaffolding RNAs and RNA processing factors. Nature Communications. 7(1). 13347–13347. 22 indexed citations
9.
Brioschi, Maura, et al.. (2015). Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor. Data in Brief. 3. 117–119. 1 indexed citations
10.
Brioschi, Maura, et al.. (2015). Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control. Journal of Proteomics. 119. 75–89. 5 indexed citations
11.
Ogo, Takeshi, Jun Yang, Lü Long, et al.. (2013). Inhibition of Overactive Transforming Growth Factor–β Signaling by Prostacyclin Analogs in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 48(6). 733–741. 42 indexed citations
12.
Nasim, Talat, et al.. (2012). BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Human Molecular Genetics. 21(11). 2548–2558. 62 indexed citations
13.
Katiyar, Sanjay, Xuanmao Jiao, Sankar Addya, et al.. (2011). Mammary Gland Selective Excision of c-Jun Identifies Its Role in mRNA Splicing. Cancer Research. 72(4). 1023–1034. 7 indexed citations
14.
Suraweera, Amila, Yi Chieh Lim, Rick Woods, et al.. (2009). Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Human Molecular Genetics. 18(18). 3384–3396. 116 indexed citations
15.
Nasim, Talat, Bhakti Patel, Victoria James, et al.. (2008). Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Human Molecular Genetics. 17(11). 1683–1694. 37 indexed citations
16.
Nasim, Talat & Ian C. Eperon. (2006). A double-reporter splicing assay for determining splicing efficiency in mammalian cells. Nature Protocols. 1(2). 1022–1028. 32 indexed citations
17.
Nasim, Talat, Ian C. Eperon, Brian M. Wilkins, & William J. Brammar. (2004). The activity of a single‐stranded promoter of plasmid ColIb‐P9 depends on its secondary structure. Molecular Microbiology. 53(2). 405–417. 24 indexed citations
18.
Nasim, Talat. (2003). HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. Human Molecular Genetics. 12(11). 1337–1348. 85 indexed citations
19.
Nasim, Talat. (2002). A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells. Nucleic Acids Research. 30(20). 109e–109. 38 indexed citations
20.
Nasim, Talat, et al.. (2000). Eukaryotic Selenocysteine Incorporation Follows a Nonprocessive Mechanism That Competes with Translational Termination. Journal of Biological Chemistry. 275(20). 14846–14852. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas A. Rado Breakdown of academic impact, for papers by Chia‐Hui Lin Breakdown of academic impact, for papers by Patricia M. Scott Breakdown of academic impact, for papers by Ewa D. Micewicz Breakdown of academic impact, for papers by Yang Wu Breakdown of academic impact, for papers by Ximeng Han Breakdown of academic impact, for papers by Yuriy O. Alekseyev Breakdown of academic impact, for papers by Tobias N. Cassel Breakdown of academic impact, for papers by Martina Klünemann
Rankless by CCL
2026